immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME External link
Filling date: 8 Sep 2025 Issue date: 16 Dec 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 14 Dec 2021
Application
Utility: Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: T CELL RECEPTORS WITH IMPROVED PAIRING External link
Filling date: 8 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS External link
Filling date: 8 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 23 Nov 2021
Application
Utility: METHOD FOR PREPARING ELECTROCOMPETENT YEAST CELLS, AND METHOD FOR USING SAID CELLS External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 9 Nov 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 8 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 8 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Immunotherapy against several tumors including lung cancer External link
Filling date: 8 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Immunotherapy against several tumors including lung cancer External link
Filling date: 8 Sep 2025 Issue date: 2 Nov 2021
Application
Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 28 Oct 2021
Grant
Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: Relaxin1 derived peptides for use in immunotherapy External link
Filling date: 8 Sep 2025 Issue date: 26 Oct 2021
Application
Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 19 Oct 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 14 Oct 2021
Grant
Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 12 Oct 2021
Grant
Utility: Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 12 Oct 2021
Application
Utility: UTERINE CANCER TREATMENTS External link
Filling date: 8 Sep 2025 Issue date: 7 Oct 2021
Grant
Utility: Immunotherapy against several tumors including neuronal and brain tumors External link
Filling date: 8 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers External link
Filling date: 8 Sep 2025 Issue date: 5 Oct 2021

Showing 150 to 200 of 820 patents.